Connor, Clark & Lunn Investment Management Ltd. Oric Pharmaceuticals, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $22 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023
BUY
$4.26 - $6.75 $6,773 - $10,732
1,590 Added 3.82%
43,225 $246,000
Q4 2022

Feb 10, 2023
SELL
$2.41 - $5.89 $22,109 - $54,034
-9,174 Reduced 18.06%
41,635 $245,000
Q3 2022

Nov 10, 2022
BUY
$3.15 - $5.24 $93,699 - $155,869
29,746 Added 141.22%
50,809 $163,000
Q2 2022

Aug 05, 2022
BUY
$2.7 - $7.07 $56,870 - $148,915
21,063 New
21,063 $94,000

Others Institutions Holding ORIC

# of Institutions
112
Shares Held
63.1M
Call Options Held
0
Put Options Held
0
View Full List

About Oric Pharmaceuticals, Inc.

ORIC Quotes by TradingView
  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $406M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email